Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sooyoung | - |
dc.contributor.author | Park, Tae Heum | - |
dc.contributor.author | Lee, Seung Min | - |
dc.contributor.author | Kim, Yon Hee | - |
dc.contributor.author | Cho, Moon Kyun | - |
dc.contributor.author | Whang, Kyu Uang | - |
dc.contributor.author | Kim, Hyun-Sook | - |
dc.date.accessioned | 2021-08-11T08:36:20Z | - |
dc.date.available | 2021-08-11T08:36:20Z | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 1396-0296 | - |
dc.identifier.issn | 1529-8019 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2891 | - |
dc.description.abstract | Scleromyxedema is a rare connective tissue disorder characterized by a generalized lichenoid eruption and sclerodermoid induration with histologic features of dermal mucin deposition. A 44-year-old man presented with a 3-year history of generalized progressive skin thickening and sclerosis. He had diffuse skin-colored to erythematous firm papules coalescing into indurated plaques over his whole body. He had been diagnosed with scleromyxedema from a skin biopsy with monoclonal gammopathy of undetermined significance (MGUS) at another tertiary hospital 3 years earlier. He had been treated with systemic corticosteroids and methotrexate, but his systemic symptoms (dyspnea, dysphagia, skin swelling, and induration) had worsened over the past year, so he visited our clinic seeking further evaluation and management. The patient received high-dose intravenous immunoglobulin (IVIG) therapy once a month in combination with systemic corticosteroids. After three courses of IVIG, his cutaneous symptoms and dyspnea had improved dramatically. Herein we report a case of scleromyxedema with systemic involvement with significant improvement following IVIG therapy. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Blackwell Publishing Inc. | - |
dc.title | Scleromyxedema with multiple systemic involvement: Successful treatment with intravenous immunoglobulin | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1111/dth.13378 | - |
dc.identifier.scopusid | 2-s2.0-85083428777 | - |
dc.identifier.wosid | 000525820500001 | - |
dc.identifier.bibliographicCitation | Dermatologic Therapy, v.33, no.3 | - |
dc.citation.title | Dermatologic Therapy | - |
dc.citation.volume | 33 | - |
dc.citation.number | 3 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Dermatology | - |
dc.relation.journalWebOfScienceCategory | Dermatology | - |
dc.subject.keywordPlus | HIGH-DOSE DEXAMETHASONE | - |
dc.subject.keywordPlus | LICHEN MYXEDEMATOSUS | - |
dc.subject.keywordPlus | PAPULAR MUCINOSIS | - |
dc.subject.keywordAuthor | immunoglobulins intravenous | - |
dc.subject.keywordAuthor | monoclonal gammopathy of undetermined significance | - |
dc.subject.keywordAuthor | scleromyxedema | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.